FSN Co., Ltd. (KOSDAQ:A214270), AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment agreed to acquire a 22.4% stake in Medifron DBT Co., Ltd. (KOSDAQ:A065650) from Hansung Cleantech Co., Ltd. (KOSDAQ:A066980) and T Scientific Co.,Ltd. (KOSDAQ:A057680) for KRW21.7 billion on February 16, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,225 KRW | -0.67% | -2.63% | -18.65% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2,225 KRW | -0.67% | -2.63% | 54.89M | ||
1,261 KRW | +6.14% | +4.56% | 59.98M | ||
1st Jan change | Capi. | |
---|---|---|
-18.65% | 54.89M | |
+15.92% | 7.19B | |
-13.16% | 1.82B | |
-2.70% | 1.3B | |
-11.28% | 1.14B | |
-37.61% | 608M | |
-6.21% | 522M | |
-29.27% | 495M | |
+11.35% | 469M | |
-30.07% | 388M |
- Stock Market
- Equities
- A214270 Stock
- News FSN Co., Ltd.
- FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment agreed to acquire a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd. for KRW21.7 billion.